Effect of Buprenorphine on reduction of withdrawal symptoms, depression and suicidal thoughts

Phase 2

• Conditions: Mental and behavioural disorders due to use of opioids; Opioid dependency.

• Registration Number: IRCT2016071325160N4
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

Inclusion Criteria:age between 16 to 60 y/o; informed consent;Opioid dependence
Exclusion criteria:Patients unwilling to participate at beginning or during the study; use of other substances except Opioid as of the main substance.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction of depression in opiod dependents and find the best choice. Timepoint: before the first dose and first day to 14 days. Method of measurement: interview and questionnaires.;Reduction of withdrawal symptoms in opiod dependents and find the best choice. Timepoint: before the first dose and first day to 14 days. Method of measurement: interview and questionnaire.;Reduction of suicidal thouhgts in opiod dependents and find the best choice. Timepoint: before the first dose and first day to 14 days. Method of measurement: interview and questionnaires.